CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222343568
- Phone
- 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 8-K Event Acquisition or sale completed · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change · Shareholder vote results · Other events
- 4 Shares withheld for taxes EVP, R&D and CMO gave up 69,959 shares (to pay taxes)
- 4 Grant or award Chief Executive Officer acquired 150,000 shares (grant or award)
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Delisting notice
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- S-4 Deal Registration Statement - Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
Page 9 of 80 · 1,583 filings